STOCK TITAN
  1. Home
  2. Sec-filings
  3. HCA
  4. [8-K] HCA Healthcare, Inc. Reports Material Event

HCA Healthcare doubles commercial paper capacity to $8B

HCA Inc., a direct wholly owned subsidiary of HCA Healthcare, Inc., increased the maximum size of its commercial paper program on July 29, 2026.

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

HCA Inc., a direct wholly owned subsidiary of HCA Healthcare, Inc., increased the maximum size of its commercial paper program on July 29, 2026. The program’s aggregate face or principal amount outstanding at any time was raised from $4.0 billion to $8.0 billion.

The unsecured commercial paper notes issued under this program are unconditionally guaranteed by HCA Healthcare, Inc., and all other terms of the program remain unchanged. The notes and related guarantee are not registered under the Securities Act of 1933 and may be offered or sold in the United States only pursuant to an applicable exemption.

Positive

  • None.

Negative

  • None.
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement Financial
The company incurred a new significant debt or off-balance-sheet obligation.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
New commercial paper program limit $8.0 billion Maximum aggregate face or principal amount outstanding at any time
Previous commercial paper program limit $4.0 billion Prior maximum aggregate face or principal amount outstanding at any time
Common stock par value $.01 per share Par value of HCA Healthcare, Inc. common stock listed on NYSE
commercial paper program financial
"increased the size of its commercial paper program under which the Issuer may issue"
A commercial paper program is a formal way a company issues very short-term IOUs to raise quick cash, typically for days to months, without using a bank loan. Investors care because it shows how the company manages short-term funding and how trustworthy it appears—like watching whether someone keeps using and repaying a credit card; frequent use or higher costs can signal cash strain, while smooth issuance suggests healthy liquidity.
unsecured commercial paper notes financial
"under which the Issuer may issue unsecured commercial paper notes (the “Notes”)"
unconditionally guaranteed financial
"The Notes are unconditionally guaranteed by the Parent Guarantor"
Securities Act of 1933 regulatory
"have not been and will not be registered under the Securities Act of 1933"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did HCA Healthcare (HCA) change in its commercial paper program?
On July 29, 2026, HCA Inc. increased its commercial paper program’s maximum aggregate face or principal amount outstanding from $4.0 billion to $8.0 billion. All other terms of the program remain as previously described by the company.

What is the new maximum amount under HCA (HCA) commercial paper program?
The program now allows up to $8.0 billion aggregate face or principal amount of unsecured commercial paper notes outstanding at any time. This is an increase from the prior maximum of $4.0 billion outstanding at any time.

Who guarantees the commercial paper notes issued by HCA Inc. (HCA)?
The unsecured commercial paper notes are unconditionally guaranteed by HCA Healthcare, Inc., acting as the Parent Guarantor. This guarantee applies to the notes issued under the expanded commercial paper program up to the new $8.0 billion limit.

Are HCA (HCA) commercial paper notes registered under the Securities Act of 1933?
No. The notes and the related guarantee have not been and will not be registered under the Securities Act of 1933 or state securities laws. They may only be offered or sold in the United States under an applicable registration exemption.

Did HCA (HCA) change any other terms of its commercial paper program?
The company states that other terms and conditions remain as previously described in its earlier disclosure. The only change highlighted is the increase in the maximum aggregate face or principal amount outstanding from $4.0 billion to $8.0 billion.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0000860730 0000860730 2026-07-29 2026-07-29
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): July 29, 2026

 

 

HCA HEALTHCARE, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-11239   27-3865930

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

One Park Plaza, Nashville, Tennessee   37203
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (615) 344-9551

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading
Symbol(s)

  

Name of each exchange

on which registered

Common Stock, $.01 par value per share   HCA   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 

Item 2.03.

Creation of a Direct Financial Obligation or an Obligation or an Off-Balance Sheet Arrangement of a Registrant.

The information set forth under Item 8.01 below is incorporated by reference into this Item 2.03.

 

Item 8.01.

Other Events

On July 29, 2026, HCA Inc. (the “Issuer”), a direct, wholly owned subsidiary of HCA Healthcare, Inc. (the “Parent Guarantor”), increased the size of its commercial paper program under which the Issuer may issue unsecured commercial paper notes (the “Notes”) from time to time from a maximum aggregate face or principal amount of $4.0 billion outstanding at any time to a maximum aggregate face or principal amount of $8.0 billion outstanding at any time. The Notes are unconditionally guaranteed by the Parent Guarantor. The other terms and conditions of the commercial paper program remain as previously described in the Parent Guarantor’s Current Report on Form 8-K filed with the Securities and Exchange Commission on June 10, 2025.

The Notes (and the related guarantee by the Parent Guarantor) have not been and will not be registered under the Securities Act of 1933, as amended (the “Securities Act”), or state securities laws and have not been and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws. The information contained in this Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy any Notes.

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

HCA HEALTHCARE, INC.
By:  

/s/ John M. Franck II

  John M. Franck II
  Vice President - Legal and Corporate Secretary

Date: July 29, 2026

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents

Other Documents

Keep reading

More on HCA

Trending in the feed

Open the live feed